Lido Advisors, LLC Akebia Therapeutics, Inc. Transaction History

Lido Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	BUY	$5.41 - $8.73 $54,024 - $87,177	9,986 Added 26.49%	47,686 $390,000
Q4 2018 Feb 14, 2019	BUY	$5.39 - $9.15 $24,352 - $41,339	4,518 Added 13.62%	37,700 $208,000
Q3 2018 Nov 14, 2018	BUY	$7.44 - $10.65 $37,572 - $53,782	5,050 Added 17.95%	33,182 $292,000
Q2 2018 Aug 14, 2018	BUY	$9.15 - $11.34 $127,386 - $157,875	13,922 Added 97.97%	28,132 $280,000
Q1 2018 May 10, 2018	BUY	$9.53 - $15.68 $135,421 - $222,812	14,210 New	14,210 $135,000

120

54.9M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $417M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lido Advisors, LLC with notifications on news.